-
DSP Healthcare Fund Regular Growth
Equity healthcare
Overview ( as on 08/12/23 )
NAV
₹28.41
Last change
₹-0.15 -0.01%
Fund Size (AUM)
1717.54 Cr
Performance
23.36% (5Y)
Fund Details
DSP Healthcare Fund Regular Growth
as of 08/12/23
AUM
1717.54 Cr
Expense Ratio
2.06 %
Benchmark
S&P BSE Healthcare TR INR
ISIN
INF740KA1LD8
Fund Manager
Jay Kothari
Exit Load
0.5% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| DSP Healthcare Fund Regular Growth | 27.96% | 14.71% | 23.36% |
| S&P BSE Healthcare TR INR | 26.85% | 14.34% | 16.21% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
12.91% |
Ipca Laboratories Ltd |
8.69% |
Cipla Ltd |
8.42% |
Suven Pharmaceuticals Ltd |
7.81% |
Lupin Ltd |
7.18% |
Apollo Hospitals Enterprise Ltd |
5.23% |
Alembic Pharmaceuticals Ltd |
5.21% |
Procter & Gamble Health Ltd |
4.71% |
Concord Biotech Ltd |
4.18% |
Alkem Laboratories Ltd |
4.07% |
Sector Allocation
Healthcare |
98.04% |
Financial |
1.96% |
Asset Allocation
-
99%
Equity
-
1%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
Nippon India Pharma IDCW-P
Equity healthcare-
Returns
-
22.8% (5Y)
-
-
Nippon India Pharma IDCW-R
Equity healthcare-
Returns
-
22.8% (5Y)
-
-
Nippon India Pharma Gr
Equity healthcare-
Returns
-
20.41% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
20.09% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
20.09% (5Y)
-
-
DSP Healthcare Fund Reg Gr
Equity healthcare-
Returns
-
23.36% (5Y)
-
